Home › Kaposi Sarcoma › New York
Kaposi Sarcoma clinical trials in New York
3 studies for Kaposi Sarcoma are looking for participants at sites in New York.
Cities in New York
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT05859074Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502Trial of Ixazomib for Kaposi Sarcoma
- Mount Sinai Hospital, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT04305691From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.